Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Updates on the hematological tumor microenvironment and its therapeutic targeting.

Forte D, Krause DS, Andreeff M, Bonnet D, Méndez-Ferrer S.

Haematologica. 2019 Sep 12. pii: haematol.2018.195396. doi: 10.3324/haematol.2018.195396. [Epub ahead of print]

2.

Remodeling of Bone Marrow Hematopoietic Stem Cell Niches Promotes Myeloid Cell Expansion during Premature or Physiological Aging.

Ho YH, Del Toro R, Rivera-Torres J, Rak J, Korn C, García-García A, Macías D, González-Gómez C, Del Monte A, Wittner M, Waller AK, Foster HR, López-Otín C, Johnson RS, Nerlov C, Ghevaert C, Vainchenker W, Louache F, Andrés V, Méndez-Ferrer S.

Cell Stem Cell. 2019 Sep 5;25(3):407-418.e6. doi: 10.1016/j.stem.2019.06.007. Epub 2019 Jul 11.

3.

Vascular Interstitial Cells in Retinal Arteriolar Annuli Are Altered During Hypertension.

Ramos D, Catita J, López-Luppo M, Valença A, Bonet A, Carretero A, Navarro M, Nacher V, Mendez-Ferrer S, Meseguer A, Casellas A, Mendes-Jorge L, Ruberte J.

Invest Ophthalmol Vis Sci. 2019 Feb 1;60(2):473-487. doi: 10.1167/iovs.18-25000.

PMID:
30707220
4.

The sympathomimetic agonist mirabegron did not lower JAK2-V617F allele burden, but restored nestin-positive cells and reduced reticulin fibrosis in patients with myeloproliferative neoplasms: results of phase II study SAKK 33/14.

Drexler B, Passweg JR, Tzankov A, Bigler M, Theocharides AP, Cantoni N, Keller P, Stussi G, Ruefer A, Benz R, Favre G, Lundberg P, Nienhold R, Fuhrer A, Biaggi C, Manz MG, Bargetzi M, Mendez-Ferrer S, Skoda RC; Swiss Group for Clinical Cancer Research (SAKK).

Haematologica. 2019 Apr;104(4):710-716. doi: 10.3324/haematol.2018.200014. Epub 2018 Nov 8.

5.

Dual cholinergic signals regulate daily migration of hematopoietic stem cells and leukocytes.

García-García A, Korn C, García-Fernández M, Domingues O, Villadiego J, Martín-Pérez D, Isern J, Bejarano-García JA, Zimmer J, Pérez-Simón JA, Toledo-Aral JJ, Michel T, Airaksinen MS, Méndez-Ferrer S.

Blood. 2019 Jan 17;133(3):224-236. doi: 10.1182/blood-2018-08-867648. Epub 2018 Oct 25.

6.

Notch2 controls non-autonomous Wnt-signalling in chronic lymphocytic leukaemia.

Mangolini M, Götte F, Moore A, Ammon T, Oelsner M, Lutzny-Geier G, Klein-Hitpass L, Williamson JC, Lehner PJ, Dürig J, Möllmann M, Rásó-Barnett L, Hughes K, Santoro A, Méndez-Ferrer S, Oostendorp RAJ, Zimber-Strobl U, Peschel C, Hodson DJ, Schmidt-Supprian M, Ringshausen I.

Nat Commun. 2018 Sep 21;9(1):3839. doi: 10.1038/s41467-018-06069-5.

7.

Daily Onset of Light and Darkness Differentially Controls Hematopoietic Stem Cell Differentiation and Maintenance.

Golan K, Kumari A, Kollet O, Khatib-Massalha E, Subramaniam MD, Ferreira ZS, Avemaria F, Rzeszotek S, García-García A, Xie S, Flores-Figueroa E, Gur-Cohen S, Itkin T, Ludin-Tal A, Massalha H, Bernshtein B, Ciechanowicz AK, Brandis A, Mehlman T, Bhattacharya S, Bertagna M, Cheng H, Petrovich-Kopitman E, Janus T, Kaushansky N, Cheng T, Sagi I, Ratajczak MZ, Méndez-Ferrer S, Dick JE, Markus RP, Lapidot T.

Cell Stem Cell. 2018 Oct 4;23(4):572-585.e7. doi: 10.1016/j.stem.2018.08.002. Epub 2018 Aug 30.

PMID:
30174297
8.

Human and mouse leukocytes: different clockwork.

Méndez-Ferrer S.

Blood. 2017 Nov 2;130(18):1960-1961. doi: 10.1182/blood-2017-09-805374. No abstract available.

9.

The evolving view of the hematopoietic stem cell niche.

Beerman I, Luis TC, Singbrant S, Lo Celso C, Méndez-Ferrer S.

Exp Hematol. 2017 Jun;50:22-26. doi: 10.1016/j.exphem.2017.01.008. Epub 2017 Feb 9. Review.

10.

Myeloid malignancies and the microenvironment.

Korn C, Méndez-Ferrer S.

Blood. 2017 Feb 16;129(7):811-822. doi: 10.1182/blood-2016-09-670224. Epub 2016 Nov 15.

11.

Role of VHL, HIF1A and SDH on the expression of miR-210: Implications for tumoral pseudo-hypoxic fate.

Merlo A, Bernardo-Castiñeira C, Sáenz-de-Santa-María I, Pitiot AS, Balbín M, Astudillo A, Valdés N, Scola B, Del Toro R, Méndez-Ferrer S, Piruat JI, Suarez C, Chiara MD.

Oncotarget. 2017 Jan 24;8(4):6700-6717. doi: 10.18632/oncotarget.14265.

12.

T-ALL: several homes rather than homeless?

Rak J, Méndez-Ferrer S.

Immunol Cell Biol. 2017 Jan;95(1):1-2. doi: 10.1038/icb.2016.103. Epub 2016 Nov 8. No abstract available.

PMID:
27824040
13.

Under Pressure: When a Transformed Environment Pushes Cells to Malignancy.

García-Fernández M, Méndez-Ferrer S.

Cell Stem Cell. 2016 Nov 3;19(5):559-560. doi: 10.1016/j.stem.2016.10.012.

14.

Nestin(+) cells direct inflammatory cell migration in atherosclerosis.

Del Toro R, Chèvre R, Rodríguez C, Ordóñez A, Martínez-González J, Andrés V, Méndez-Ferrer S.

Nat Commun. 2016 Sep 2;7:12706. doi: 10.1038/ncomms12706.

15.

The hematopoietic stem-cell niche in health and leukemia.

Sánchez-Aguilera A, Méndez-Ferrer S.

Cell Mol Life Sci. 2017 Feb;74(4):579-590. doi: 10.1007/s00018-016-2306-y. Epub 2016 Jul 19. Review.

16.

Regulation of hematopoietic progenitors by estrogens as a basis for new antileukemic strategies.

Sánchez-Aguilera A, Méndez-Ferrer S.

Mol Cell Oncol. 2015 Feb 3;3(1):e1009728. doi: 10.1080/23723556.2015.1009728. eCollection 2016 Jan.

17.

A Novel Systems-Biology Algorithm for the Analysis of Coordinated Protein Responses Using Quantitative Proteomics.

García-Marqués F, Trevisan-Herraz M, Martínez-Martínez S, Camafeita E, Jorge I, Lopez JA, Méndez-Barbero N, Méndez-Ferrer S, Del Pozo MA, Ibáñez B, Andrés V, Sánchez-Madrid F, Redondo JM, Bonzon-Kulichenko E, Vázquez J.

Mol Cell Proteomics. 2016 May;15(5):1740-60. doi: 10.1074/mcp.M115.055905. Epub 2016 Feb 18.

18.

BMSCs and hematopoiesis.

García-García A, de Castillejo CL, Méndez-Ferrer S.

Immunol Lett. 2015 Dec;168(2):129-35. doi: 10.1016/j.imlet.2015.06.020. Epub 2015 Jul 17. Review.

PMID:
26192443
19.

Convert and conquer: the strategy of chronic myelogenous leukemic cells.

Méndez-Ferrer S, García-Fernández M, de Castillejo CL.

Cancer Cell. 2015 May 11;27(5):611-3. doi: 10.1016/j.ccell.2015.04.012.

20.

Bone marrow stem cells: current and emerging concepts.

Méndez-Ferrer S, Scadden DT, Sánchez-Aguilera A.

Ann N Y Acad Sci. 2015 Jan;1335:32-44. doi: 10.1111/nyas.12641. Review.

PMID:
25573321
21.

Estrogen signaling selectively induces apoptosis of hematopoietic progenitors and myeloid neoplasms without harming steady-state hematopoiesis.

Sánchez-Aguilera A, Arranz L, Martín-Pérez D, García-García A, Stavropoulou V, Kubovcakova L, Isern J, Martín-Salamanca S, Langa X, Skoda RC, Schwaller J, Méndez-Ferrer S.

Cell Stem Cell. 2014 Dec 4;15(6):791-804. doi: 10.1016/j.stem.2014.11.002.

22.

Low/negative expression of PDGFR-α identifies the candidate primary mesenchymal stromal cells in adult human bone marrow.

Li H, Ghazanfari R, Zacharaki D, Ditzel N, Isern J, Ekblom M, Méndez-Ferrer S, Kassem M, Scheding S.

Stem Cell Reports. 2014 Dec 9;3(6):965-74. doi: 10.1016/j.stemcr.2014.09.018. Epub 2014 Oct 30.

23.

The neural crest is a source of mesenchymal stem cells with specialized hematopoietic stem cell niche function.

Isern J, García-García A, Martín AM, Arranz L, Martín-Pérez D, Torroja C, Sánchez-Cabo F, Méndez-Ferrer S.

Elife. 2014 Sep 25;3:e03696. doi: 10.7554/eLife.03696.

24.

Inhibiting stromal cell heparan sulfate synthesis improves stem cell mobilization and enables engraftment without cytotoxic conditioning.

Saez B, Ferraro F, Yusuf RZ, Cook CM, Yu VW, Pardo-Saganta A, Sykes SM, Palchaudhuri R, Schajnovitz A, Lotinun S, Lymperi S, Mendez-Ferrer S, Toro RD, Day R, Vasic R, Acharya SS, Baron R, Lin CP, Yamaguchi Y, Wagers AJ, Scadden DT.

Blood. 2014 Nov 6;124(19):2937-47. doi: 10.1182/blood-2014-08-593426. Epub 2014 Sep 8.

25.

Neuropathy of haematopoietic stem cell niche is essential for myeloproliferative neoplasms.

Arranz L, Sánchez-Aguilera A, Martín-Pérez D, Isern J, Langa X, Tzankov A, Lundberg P, Muntión S, Tzeng YS, Lai DM, Schwaller J, Skoda RC, Méndez-Ferrer S.

Nature. 2014 Aug 7;512(7512):78-81. doi: 10.1038/nature13383. Epub 2014 Jun 22.

PMID:
25043017
26.

Autonomic regulation of hematopoiesis and cancer.

del Toro R, Méndez-Ferrer S.

Haematologica. 2013 Nov;98(11):1663-6. doi: 10.3324/haematol.2013.084764. No abstract available.

27.

Cell biology: tumour stem cells in bone.

Zaidi M, Méndez-Ferrer S.

Nature. 2013 Jul 25;499(7459):414-6. doi: 10.1038/nature12412. Epub 2013 Jul 17. No abstract available.

28.

Mitochondria underlie different metabolism of hematopoietic stem and progenitor cells.

Arranz L, Urbano-Ispizúa A, Méndez-Ferrer S.

Haematologica. 2013 Jul;98(7):993-5. doi: 10.3324/haematol.2013.084293. No abstract available.

29.

Self-renewing human bone marrow mesenspheres promote hematopoietic stem cell expansion.

Isern J, Martín-Antonio B, Ghazanfari R, Martín AM, López JA, del Toro R, Sánchez-Aguilera A, Arranz L, Martín-Pérez D, Suárez-Lledó M, Marín P, Van Pel M, Fibbe WE, Vázquez J, Scheding S, Urbano-Ispizúa Á, Méndez-Ferrer S.

Cell Rep. 2013 May 30;3(5):1714-24. doi: 10.1016/j.celrep.2013.03.041. Epub 2013 Apr 25.

30.

Intercapillary bridging cells: immunocytochemical characteristics of cells that connect blood vessels in the retina.

Mendes-Jorge L, Llombart C, Ramos D, López-Luppo M, Valença A, Nacher V, Navarro M, Carretero A, Méndez-Ferrer S, Rodriguez-Baeza A, Ruberte J.

Exp Eye Res. 2012 May;98:79-87. doi: 10.1016/j.exer.2012.03.010. Epub 2012 Mar 29.

PMID:
22484557
31.

Norepinephrine reuptake inhibition promotes mobilization in mice: potential impact to rescue low stem cell yields.

Lucas D, Bruns I, Battista M, Mendez-Ferrer S, Magnon C, Kunisaki Y, Frenette PS.

Blood. 2012 Apr 26;119(17):3962-5. doi: 10.1182/blood-2011-07-367102. Epub 2012 Mar 14.

32.

Diabetes impairs hematopoietic stem cell mobilization by altering niche function.

Ferraro F, Lymperi S, Méndez-Ferrer S, Saez B, Spencer JA, Yeap BY, Masselli E, Graiani G, Prezioso L, Rizzini EL, Mangoni M, Rizzoli V, Sykes SM, Lin CP, Frenette PS, Quaini F, Scadden DT.

Sci Transl Med. 2011 Oct 12;3(104):104ra101. doi: 10.1126/scitranslmed.3002191.

33.

Stem cell interactions in a bone marrow niche.

Isern J, Méndez-Ferrer S.

Curr Osteoporos Rep. 2011 Dec;9(4):210-8. doi: 10.1007/s11914-011-0075-y. Review.

PMID:
21932020
34.

Stem cell self-renewal: lessons from bone marrow, gut and iPS toward clinical applications.

Staal FJ, Baum C, Cowan C, Dzierzak E, Hacein-Bey-Abina S, Karlsson S, Lapidot T, Lemischka I, Mendez-Ferrer S, Mikkers H, Moore K, Moreno E, Mummery CL, Robin C, Suda T, Van Pel M, Vanden Brink G, Zwaginga JJ, Fibbe WE.

Leukemia. 2011 Jul;25(7):1095-102. doi: 10.1038/leu.2011.52. Epub 2011 Apr 29. Review.

PMID:
21527933
35.

Bone marrow mesenchymal stem and progenitor cells induce monocyte emigration in response to circulating toll-like receptor ligands.

Shi C, Jia T, Mendez-Ferrer S, Hohl TM, Serbina NV, Lipuma L, Leiner I, Li MO, Frenette PS, Pamer EG.

Immunity. 2011 Apr 22;34(4):590-601. doi: 10.1016/j.immuni.2011.02.016. Epub 2011 Mar 31.

36.

Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche.

Chow A, Lucas D, Hidalgo A, Méndez-Ferrer S, Hashimoto D, Scheiermann C, Battista M, Leboeuf M, Prophete C, van Rooijen N, Tanaka M, Merad M, Frenette PS.

J Exp Med. 2011 Feb 14;208(2):261-71. doi: 10.1084/jem.20101688. Epub 2011 Jan 31.

37.

Mesenchymal and haematopoietic stem cells form a unique bone marrow niche.

Méndez-Ferrer S, Michurina TV, Ferraro F, Mazloom AR, Macarthur BD, Lira SA, Scadden DT, Ma'ayan A, Enikolopov GN, Frenette PS.

Nature. 2010 Aug 12;466(7308):829-34. doi: 10.1038/nature09262.

38.

Cooperation of beta(2)- and beta(3)-adrenergic receptors in hematopoietic progenitor cell mobilization.

Méndez-Ferrer S, Battista M, Frenette PS.

Ann N Y Acad Sci. 2010 Mar;1192:139-44. doi: 10.1111/j.1749-6632.2010.05390.x.

39.

Galpha(s) uncouples hematopoietic stem cell homing and mobilization.

Méndez-Ferrer S, Frenette PS.

Cell Stem Cell. 2009 May 8;4(5):379-80. doi: 10.1016/j.stem.2009.04.009.

40.

Circadian rhythms influence hematopoietic stem cells.

Méndez-Ferrer S, Chow A, Merad M, Frenette PS.

Curr Opin Hematol. 2009 Jul;16(4):235-42. doi: 10.1097/MOH.0b013e32832bd0f5. Review.

41.

Haematopoietic stem cell release is regulated by circadian oscillations.

Méndez-Ferrer S, Lucas D, Battista M, Frenette PS.

Nature. 2008 Mar 27;452(7186):442-7. doi: 10.1038/nature06685. Epub 2008 Feb 6.

PMID:
18256599
42.

Hematopoietic stem cell trafficking: regulated adhesion and attraction to bone marrow microenvironment.

Méndez-Ferrer S, Frenette PS.

Ann N Y Acad Sci. 2007 Nov;1116:392-413. Review.

PMID:
18083941
43.

Carotid body autotransplantation in Parkinson disease: a clinical and positron emission tomography study.

Mínguez-Castellanos A, Escamilla-Sevilla F, Hotton GR, Toledo-Aral JJ, Ortega-Moreno A, Méndez-Ferrer S, Martín-Linares JM, Katati MJ, Mir P, Villadiego J, Meersmans M, Pérez-García M, Brooks DJ, Arjona V, López-Barneo J.

J Neurol Neurosurg Psychiatry. 2007 Aug;78(8):825-31. Epub 2007 Jan 12.

44.

Resident progenitors and bone marrow stem cells in myocardial renewal and repair.

Méndez-Ferrer S, Ellison GM, Torella D, Nadal-Ginard B.

Nat Clin Pract Cardiovasc Med. 2006 Mar;3 Suppl 1:S83-9. Review.

PMID:
16501639
45.

Resident human cardiac stem cells: role in cardiac cellular homeostasis and potential for myocardial regeneration.

Torella D, Ellison GM, Méndez-Ferrer S, Ibanez B, Nadal-Ginard B.

Nat Clin Pract Cardiovasc Med. 2006 Mar;3 Suppl 1:S8-13. Review.

PMID:
16501638
46.

Selective glial cell line-derived neurotrophic factor production in adult dopaminergic carotid body cells in situ and after intrastriatal transplantation.

Villadiego J, Méndez-Ferrer S, Valdés-Sánchez T, Silos-Santiago I, Fariñas I, López-Barneo J, Toledo-Aral JJ.

J Neurosci. 2005 Apr 20;25(16):4091-8.

47.

Autotransplantation of human carotid body cell aggregates for treatment of Parkinson's disease.

Arjona V, Mínguez-Castellanos A, Montoro RJ, Ortega A, Escamilla F, Toledo-Aral JJ, Pardal R, Méndez-Ferrer S, Martín JM, Pérez M, Katati MJ, Valencia E, García T, López-Barneo J.

Neurosurgery. 2003 Aug;53(2):321-8; discussion 328-30.

PMID:
12925247
48.

Trophic restoration of the nigrostriatal dopaminergic pathway in long-term carotid body-grafted parkinsonian rats.

Toledo-Aral JJ, Méndez-Ferrer S, Pardal R, Echevarría M, López-Barneo J.

J Neurosci. 2003 Jan 1;23(1):141-8.

49.

Dopaminergic cells of the carotid body: physiological significance and possible therapeutic applications in Parkinson's disease.

Toledo-Aral JJ, Méndez-Ferrer S, Pardal R, López-Barneo J.

Brain Res Bull. 2002 Apr;57(6):847-53. Review.

PMID:
12031283
50.

Identification of a new water channel (Rp-MIP) in the Malpighian tubules of the insect Rhodnius prolixus.

Echevarría M, Ramírez-Lorca R, Hernández CS, Gutiérrez A, Méndez-Ferrer S, González E, Toledo-Aral JJ, Ilundáin AA, Whittembury G.

Pflugers Arch. 2001 Apr;442(1):27-34.

PMID:
11374065

Supplemental Content

Loading ...
Support Center